Sunil Agarwal, Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 1,041 shares at $72.83 ($75K) on 2016-01-20, disclosed to the SEC on 2016-01-21.
Scheduled sale ($75k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.52 | 456 | $33K | 43.4% |
| 2 | $72.83 | 585 | $43K | 56.6% |
| Total | $72.26 avg | 1,041 | $75K | 100% |
| Filing → |
| RARE | SELL | 2016-07-21 | $34K | — | Filing → |
| RARE | SELL | 2016-06-21 | $35K | — | Filing → |
| RARE | SELL | 2016-05-26 | $43K | — | Filing → |